Education
About Us
Working with TipRanks
Follow Us
Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167)
:1167
RESEARCH TOOLSreports
Total Valuation
Jacobio Pharmaceuticals Group Co., Ltd. has a market cap or net worth of HK$4.24B. The enterprise value is HK$2.34B.
Market CapHK$4.24B
Enterprise ValueHK$2.34B
Share Statistics
Jacobio Pharmaceuticals Group Co., Ltd. has 791,755,070 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding791,755,070
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jacobio Pharmaceuticals Group Co., Ltd.’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -15.92%.
Return on Equity (ROE)-0.17
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-15.92%
Return on Capital Employed (ROCE)-0.17
Revenue Per Employee605.87K
Profits Per Employee-605.87K
Employee Count257
Asset Turnover0.11
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Jacobio Pharmaceuticals Group Co., Ltd. is -5.94. Jacobio Pharmaceuticals Group Co., Ltd.’s PEG ratio is -0.33.
PE Ratio-5.94
PS Ratio0.00
PB Ratio2.71
Price to Fair Value1.00
Price to FCF-11.24
Price to Operating Cash Flow-11.87
PEG Ratio-0.33
Income Statement
In the last 12 months, Jacobio Pharmaceuticals Group Co., Ltd. had revenue of 155.71M and earned -155.71M in profits. Earnings per share was -0.20.
Revenue155.71M
Gross Profit155.71M
Operating Income-188.17M
Pretax Income-155.71M
Net Income-155.71M
EBITDA-192.36M
Earnings Per Share (EPS)-0.20
Cash Flow
In the last 12 months, operating cash flow was -180.43M and capital expenditures -5.48M, giving a free cash flow of -185.90M billion.
Operating Cash Flow-180.43M
Free Cash Flow-185.90M
Free Cash Flow per Share-0.23
Dividends & Yields
Jacobio Pharmaceuticals Group Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.43
52-Week Price Change224.85%
50-Day Moving Average4.23
200-Day Moving Average2.44
Relative Strength Index (RSI)57.48
Average Volume (3m)7.62M
Important Dates
Jacobio Pharmaceuticals Group Co., Ltd. upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateMar 19, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Jacobio Pharmaceuticals Group Co., Ltd. as a current ratio of 4.89, with Debt / Equity ratio of 11.52%
Current Ratio4.89
Quick Ratio4.88
Debt to Market Cap0.08
Net Debt to EBITDA5.32
Interest Coverage Ratio-22.40
Taxes
In the past 12 months, Jacobio Pharmaceuticals Group Co., Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Jacobio Pharmaceuticals Group Co., Ltd. EV to EBITDA ratio is 0.51, with an EV/FCF ratio of 1.14.
EV to Sales-0.63
EV to EBITDA0.51
EV to Free Cash Flow1.14
EV to Operating Cash Flow1.33
Balance Sheet
Jacobio Pharmaceuticals Group Co., Ltd. has HK$1.17B in cash and marketable securities with ¥152.08M in debt, giving a net cash position of -HK$1.02B billion.
Cash & Marketable SecuritiesHK$1.17B
Total Debt¥152.08M
Net Cash-HK$1.02B
Net Cash Per Share-HK$1.29
Tangible Book Value Per ShareHK$1.19
Margins
Gross margin is 13.20%, with operating margin of -120.85%, and net profit margin of -100.00%.
Gross Margin13.20%
Operating Margin-120.85%
Pretax Margin-100.00%
Net Profit Margin-100.00%
EBITDA Margin-123.54%
EBIT Margin-130.49%
Analyst Forecast
The average price target for Jacobio Pharmaceuticals Group Co., Ltd. is HK$2.05, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$2.05
Price Target Upside-60.35% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast139.04%
EPS Growth Forecast57.13%